This article is from the source 'independent' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.independent.co.uk/news/world/europe/france-clinical-trial-prosecutors-investigating-accident-as-biotrial-defends-drug-testing-safety-a6814641.html
The article has changed 3 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
France clinical trial: Prosecutors investigating 'accident' as Biotrial defends drug testing safety record | France clinical trial: Prosecutors investigating 'accident' as Biotrial defends drug testing safety record |
(35 minutes later) | |
Prosecutors have opened an investigation into how a volunteer trialling an experimental painkiller was left brain-dead and five more in hospital in France. | |
All six patients were volunteers in a clinical trial being undertaken by research company Biotrial for the reported drug manufacturers, Bial. | |
A spokesperson for Biotrial said it was being conducted in “full compliance with international regulations” and its own procedures, which includes health monitoring. | A spokesperson for Biotrial said it was being conducted in “full compliance with international regulations” and its own procedures, which includes health monitoring. |
“We are in close and regular contact with the health ministry and authorities in France,” the company said in a statement. | “We are in close and regular contact with the health ministry and authorities in France,” the company said in a statement. |
“The priority at Biotrial remains the safety of our subjects. | “The priority at Biotrial remains the safety of our subjects. |
“We are very grateful for the support we have been receiving from our clients and partners today.” | “We are very grateful for the support we have been receiving from our clients and partners today.” |
The French health ministry announced what it called a “serious accident” on Friday, saying the trial had been suspended and all volunteers recalled. | The French health ministry announced what it called a “serious accident” on Friday, saying the trial had been suspended and all volunteers recalled. |
A statement released today did not confirm the name of the drug being tested but French media reports claimed it was a new cannabinoid-based painkiller. | A statement released today did not confirm the name of the drug being tested but French media reports claimed it was a new cannabinoid-based painkiller. |
Marisol Touraine, the French health minister, later said that the pill did not contain cannabis or its derivatives but acted on the body's endocannabinoid system. | |
Taken orally, the drug was undergoing a Phase 1 clinical trial at a licensed private European laboratory that specialises in clinical trials, a spokesperson said. | |
The trial aimed to evaluate the “safety, tolerance and pharmaceutical properties of the molecule” in healthy volunteers. | The trial aimed to evaluate the “safety, tolerance and pharmaceutical properties of the molecule” in healthy volunteers. |
The person since declared brain-dead was admitted to Rennes University Hospital on Monday but the first patient in the case had entered the previous day. | The person since declared brain-dead was admitted to Rennes University Hospital on Monday but the first patient in the case had entered the previous day. |
Other patients went in on Wednesday and Thursday, while the sixth was taken in this morning as a precaution. Two others were involved in the trial but had taken a placebo,Ouest France reported. | Other patients went in on Wednesday and Thursday, while the sixth was taken in this morning as a precaution. Two others were involved in the trial but had taken a placebo,Ouest France reported. |
Marisol Touraine, the French health minister, was in Rennes this afternoon to meet the patients’ families and hold a press conference with the CEO of Biotrial, Jean-Marc Gandon, after ordering an investigation. | Marisol Touraine, the French health minister, was in Rennes this afternoon to meet the patients’ families and hold a press conference with the CEO of Biotrial, Jean-Marc Gandon, after ordering an investigation. |
Biotrial, with headquarters in Rennes and offices in London and Newark, New Jersey, says on its website it has over 25 years of experience in clinical trials and uses “state-of-the-art facilities.” In France, adults volunteering for Biotrial tests can earn between €100 and €4,500 (£76 to £3,400). | Biotrial, with headquarters in Rennes and offices in London and Newark, New Jersey, says on its website it has over 25 years of experience in clinical trials and uses “state-of-the-art facilities.” In France, adults volunteering for Biotrial tests can earn between €100 and €4,500 (£76 to £3,400). |
France’s medicines agency (ANSM) has launched an investigation into the laboratory. | France’s medicines agency (ANSM) has launched an investigation into the laboratory. |
A spokesperson for the European Medicines Agency in London said it did not have full details of the case but that it was monitoring the situation. | A spokesperson for the European Medicines Agency in London said it did not have full details of the case but that it was monitoring the situation. |
The last drug trial disaster in Europe occurred in 2006, when six healthy volunteers given an experimental drug in London ended up in intensive care. | The last drug trial disaster in Europe occurred in 2006, when six healthy volunteers given an experimental drug in London ended up in intensive care. |
One of them was described as looking like “the elephant man” after his head swelled up, while another volunteer lost his fingertips and toes. | One of them was described as looking like “the elephant man” after his head swelled up, while another volunteer lost his fingertips and toes. |
Additional reporting by agencies | Additional reporting by agencies |